In the current trading session, Psyence Biomedical Ltd’s (PBM) stock is trading at the price of $0.04, a fall of -2.07% over last night’s close. So, the stock is trading at a price that is -99.69% less than its 52-week high of $13.69 and 0.24% better than its 52-week low of $0.04. Based on the past 30-day period, the stock price is -59.72% below the high and +6.48% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, PBM’s SMA-200 is $0.5456.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How does Psyence Biomedical Ltd (PBM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Psyence Biomedical Ltd (NASDAQ: PBM) Ownership Details
I will give a breakdown of the key shareholders in Psyence Biomedical Ltd (PBM). Recent figures show that the company’s insiders hold 11.14% of shares. A total of 15 institutional investors hold shares in the company, making 8.98% of its stock and 10.10% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is AdvisorShares Investments, LLC holding total of 1.23 shares that make 1.94% of the company’s total number of shares and are currently priced at 52992.0.
The securities firm Cantor Fitzgerald, L.P. holds 337.0 shares of PBM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.53%, and the holding percentage of shares is valued at 14491.0.
An overview of Psyence Biomedical Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Psyence Biomedical Ltd (PBM) traded 8,771,730 shares per day, with a moving average of $0.0633 and price change of -0.0523. With the moving average of $0.0900 and a price change of -0.0843, about 8,481,008 shares changed hands on average over the past 50 days. Finally, PBM’s 100-day average volume is 6,200,632 shares, alongside a moving average of $0.2526 and a price change of -0.2483.
